期刊文献+

围绝经期综合征中医证素与血脂血糖等的相关研究 被引量:2

Relationship among TCM Syndrome Elements,Blood Lipid,Blood Glucose and Other Indexes in Perimenopausal Syndrome
下载PDF
导出
摘要 目的探讨围绝经期综合征妇女常见证素与血脂等指标的相关性。方法选择174例围绝经期综合征患者,采用辨证要素积分方法,通过对患者血脂等指标的观察,研究围绝经期综合征中医证素与血脂等的相关性。结果绝经组LDL-C、TG、TC、TG/TC水平明显高于未绝经组,HDL-C、HDL-C/LDL-C水平明显低于未绝经组。FPG与肝、肾、气虚、血虚呈正相关;HDL-C与肾、脾、湿呈负相关;HDL-C/LDL-C与湿呈负相关;TG/TC与脾、痰呈正相关;ApoB与肝呈正相关。结论血脂等指标变化与围绝经期综合征证素的形成有关。 Objective To discuss the relationship among syndrome elements,blood lipid and other indexes in perimenopausal syndrome(PS) women. Methods 174 PS patients were selected and the method of syndrome elements differentiation wsa used. The blood lipid and other indexes in PS patients were observed and the relationship among syndrome elements,blood lipid and other indexes was explored. Results The levels of LDL-C,TG,TC and TG / TC in menopause group were significantly higher than those of non-menopause group,and the levels of HDL-C and HDL-C / LDL-C were significantly lower than those of nonmenopause group. The FPG level was positively related to liver,kidney,Qi deficiency and blood deficiency,and the HDL-C level was negatively related to kidney,spleen and moisture. HDL-C / LDL-C was negatively related to moisture,TG / TC was positively related to spleen and phlegm,and ApoB was positively related to liver. Conclusion The changes of blood lipid and other indexes in PS patients are related to the formation of syndrome elements.
出处 《福建中医药大学学报》 2013年第4期1-3,共3页 Journal of Fujian College of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(30772697) 福建省教育厅A类科技项目(JA10164)
关键词 围绝经期综合征 证素 血脂 血糖 perimenopausal syndrome syndrome element blood lipid blood glucose
  • 相关文献

参考文献5

二级参考文献18

  • 1王天德.实用中西医结合[M].北京:中国中医药出版社,1998.68.6.
  • 2华琪.单纯肥胖症[M].北京:北京科学技术出版社,1998.1.
  • 3Lerner DJ,Kannel.Patterns of Coronary heart disease morbidity and mortality in the sexes,A 26 year follow-up of the Framinham population[J].Am Heart J,1986,111 (2):283 -290.
  • 4Shepherd J.Lipoprotein metabolism:an overview[J].Drugs,1994,47 (Suppl2):1-10.
  • 5Stampfer M,Colditz GA.Estorgen on replacement therapy and coronary heart disease:a quantitative assessment of the epidemiologic evidence[J].Prev Med,1991,20(1):47 -63.
  • 6Wolf PH,Madans JH.Reduction of cardiovascular disease related mortality among postmenopausal women who use hormones.Evidence from a national cohort[J].Am Obstet Gynecol,1997,146:489-595.
  • 7Walsh BW,Schiff I,Rosner B,et al.Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins[J].N Engl J Med,1991,325 (17):1196-1204.
  • 8Shahar E,Folson AR,Salomaa VV,et al.Relation of hormone replacement therapy to measures of plasma fibrinolytic activity.Atherosclerosis Risk in Communities ARIC) Study Investigators.[J].Circulation,1996,93(11):1970-1975.
  • 9Farhat MY,Abi-Younes S,Ramwell PW,et al.Non-genomic effects of estrogen and the vessel wall[J].Biochem Pharmacol,1996,51(5):571 -576.
  • 10Rossouw JE,Anderson GL,Prentice RL,et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results From the Women's Health Initiative randomized controlled trial[J].JAMA,2002,288 (3):321-333.

共引文献24

同被引文献28

引证文献2

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部